EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtÜbersichtsarbeit

Cerebral Embolic Protection Devices for the Prevention of Stroke in Patients Undergoing Transcatheter Aortic Valve Implantation: An Updated Meta‐Analysis of Randomized Controlled Trials

Ahmed Nazmy iD, Ahmed Sobhy, Ahmed Elshahat iD, Ahmed Abdelaziz, Ebtsam Makhlouf, Amira Fahmy El-Nemr, Mohammed Sabri Hassanin, Karim Atta, Ahmed Yasser Shaban iD, Mahmoud Nazmy, Rajesh K Kharbanda, Basel Abdelazeem iD und 1 weitere

Catheterization and Cardiovascular Interventions · 2026

DOI: 10.1002/ccd.70411 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Catheterization and Cardiovascular Interventions, 2026. Verfasst von Ahmed Nazmy und 12 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Group of Egypt (MRGE), Negida Academy, Arlington, Massachusetts, USA. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Embolic Protection Devices, Stroke, Intracranial Embolism. Die Arbeit nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stroke remains one of the most devastating complications following transcatheter aortic valve implantation (TAVI). Although cerebral embolic protection devices (CEPDs) have emerged to mitigate patients' risks, their impact on stroke risk, as well as other clinical and neurocognitive outcomes after TAVI, remains uncertain. We aimed to assess whether CEPDs alleviate stroke risks and neurocognitive outcomes after TAVI. We systematically searched MEDLINE, Scopus, Web of Science (WOS), and the Cochrane CENTRAL from inception until May 2025. We included randomized controlled trials (RCTs) that assessed the effectiveness of CEPD compared to the control group (no CEPD) in adult patients (> 18 years) undergoing TAVI. The primary endpoint was the incidence of all‐cause stroke. In contrast, the secondary endpoints included disabling stroke, systemic bleeding, transient ischemic attack (TIA), and major adverse cardiovascular and cerebrovascular events (MACCE). Additionally, we assessed neurological outcomes, including changes in the Montreal Cognitive Assessment (MoCA) score, the National Institutes of Health Stroke Scale (NIHSS) score, and the presence of new ischemic lesions. Nine RCTs comprising 11,696 patients were included in the final analysis. The use of CEPDs showed no statistical difference in reducing all‐cause stroke compared to the control group (OR = 0.91, 95% CI [0.73–1.15], p = 0.44). Additionally, there was no significant difference in other studies' secondary outcomes, including disabling stroke, MACCE, systemic bleeding, or neurological outcomes, such as worsening NISSS, decline in MoCA score, and the presence of new ischemic lesions. The use of CEPD during TAVI showed no benefit in reducing the risks of all‐cause stroke and other neurological outcomes studied.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementEmbolic Protection DevicesStrokeIntracranial EmbolismAortic Valve StenosisHumansRandomized Controlled Trials as TopicTreatment OutcomeRisk FactorsRisk AssessmentAgedMaleAged, 80 and overFemaleProtective FactorsCognition

Stichwörter der Autor:innen

cerebral embolic protection devicemeta‐analysisstroketranscatheter aortic valve implantation

Autor:innen und Institutionen

  • Medical Research Group of Egypt (MRGE), Negida Academy, Arlington, Massachusetts, USA.
  • Faculty of Medicine, Kafr-Elsheikh University, Kafr-Elsheikh, Egypt.
  • Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
  • Division of Cardiology, Montefiore Health System/Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, USA.
  • Department of Cardiology, Faculty of Medicine, Minia University, Minia, Egypt.
  • Institute of Medicine, National Research Mordovia State University, Saransk, Russia.

ORCID-Profile: Ahmed Nazmy, Ahmed Elshahat, Ahmed Yasser Shaban, Basel Abdelazeem, Mamas A Mamas

Zitieren

APA

Nazmy, A., Sobhy, A., Elshahat, A., Abdelaziz, A., Makhlouf, E., El-Nemr, A. F., Hassanin, M. S., Atta, K., Shaban, A. Y., Nazmy, M., Kharbanda, R. K., Abdelazeem, B., & Mamas, M. A. (2026). Cerebral Embolic Protection Devices for the Prevention of Stroke in Patients Undergoing Transcatheter Aortic Valve Implantation: An Updated Meta‐Analysis of Randomized Controlled Trials. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70411

Vancouver

Nazmy A, Sobhy A, Elshahat A, Abdelaziz A, Makhlouf E, El-Nemr AF, et al. Cerebral Embolic Protection Devices for the Prevention of Stroke in Patients Undergoing Transcatheter Aortic Valve Implantation: An Updated Meta‐Analysis of Randomized Controlled Trials. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70411

BibTeX
@article{Nazmy2026,
  author = {Nazmy, Ahmed and Sobhy, Ahmed and Elshahat, Ahmed and Abdelaziz, Ahmed and Makhlouf, Ebtsam and El-Nemr, Amira Fahmy and Hassanin, Mohammed Sabri and Atta, Karim and Shaban, Ahmed Yasser and Nazmy, Mahmoud and Kharbanda, Rajesh K and Abdelazeem, Basel and Mamas, Mamas A},
  title = {Cerebral Embolic Protection Devices for the Prevention of Stroke in Patients Undergoing Transcatheter Aortic Valve Implantation: An Updated Meta‐Analysis of Randomized Controlled Trials},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  doi = {10.1002/ccd.70411}
}
Kostenlos starten →